(Namita Pradhan, Intern Journalist) Bengaluru; Zydus, The India pharmaceutical company has started human studies for its Coronavirus Vaccine on Wednesday (15th July). As India to be on the third list of the world’s most affected countries by Covid-19. It has been important to find out its vaccine.
ZyCoV-D, its plasmid DNA vaccine was claimed to be safe, immunogenic and in the pre-clinical toxicity studies, it was well tolerated.
About Post Author
